KTTA
Pasithea TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
KTTA vs peer average
64/100
KTTA vs. peer average (C vs. D)
Grade spread
B 2 · C 1 · D 3 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
HIND is the first available peer comparator.
Loose same-sector microcap comparator; useful mainly for financing and clinical-event volatility context.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KTTA
Pasithea Therapeutics
HIND
Vyome
Grade
C
D
Momentum
83
33
Value
57
54
Sentiment
57
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs HIND
KTTA / HIND
Grade Position
In line
KTTA vs. peer average (C vs. D)
64/100
Momentum
83
KTTAValue
57
KTTASentiment
57
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KTTA
HIND is the first peer returned for this comparison set.